These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3513995)

  • 21. Effect of rifampicin on cyclosporin A blood levels in a renal transplant recipient.
    Cassidy MJ; Van Zyl-Smit R; Pascoe MD; Swanepoel CR; Jacobson JE
    Nephron; 1985; 41(2):207-8. PubMed ID: 3900779
    [No Abstract]   [Full Text] [Related]  

  • 22. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients.
    Jung K; Neumann R; Scholz D; Nugel E
    Clin Nephrol; 1982 Apr; 17(4):191-4. PubMed ID: 7042146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum lipid pattern unifies following renal transplantation in children.
    Müller T; Koeppe S; Arbeiter K; Luckner D; Salzer U; Balzar E; Aufricht C
    Pediatr Nephrol; 2003 Sep; 18(9):939-42. PubMed ID: 12883978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cyclosporin-ticarcillin interaction in a renal transplant patient].
    Lambert C; Pointet P; Ducret F
    Presse Med; 1989 Feb; 18(5):230. PubMed ID: 2522215
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood cyclosporin concentrations and renal allograft dysfunction.
    De Vecchi A; Rosso di San Secondo VE
    Br Med J (Clin Res Ed); 1986 Dec; 293(6561):1570-1. PubMed ID: 3099967
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood cyclosporin concentrations and renal allograft dysfunction.
    Lui SF; Varghese Z; Sweny P; Fernando ON; Moorhead JF
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1435. PubMed ID: 3099900
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction between cyclosporin and erythromycin in a kidney transplant patient.
    Kessler M; Louis J; Renoult E; Vigneron B; Netter P
    Eur J Clin Pharmacol; 1986; 30(5):633-4. PubMed ID: 3530783
    [No Abstract]   [Full Text] [Related]  

  • 31. High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia.
    Nemunaitis J; Deeg HJ; Yee GC
    Lancet; 1986 Sep; 2(8509):744-5. PubMed ID: 2876205
    [No Abstract]   [Full Text] [Related]  

  • 32. Convulsions associated with cyclosporin A in renal transplant recipients.
    Beaman M; Parvin S; Veitch PS; Walls J
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):139-40. PubMed ID: 3917716
    [No Abstract]   [Full Text] [Related]  

  • 33. Gel chromatographic analysis of cyclosporin and its metabolites in human blood compartments.
    Kodobayashi M; Yamamoto K; Takahara S; Okuyama A; Takashima N; Sawada M; Yanaihara C; Kurokawa N
    J Pharm Pharmacol; 1995 Aug; 47(8):693-7. PubMed ID: 8583375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.
    Hamberger C; Urien S; Barre J; Brandebourger M; Lemaire M; Lang P; Buisson C; Loisance D; Cachera JP; Lagrue G
    Ther Drug Monit; 1988; 10(1):28-33. PubMed ID: 3287706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
    Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
    [No Abstract]   [Full Text] [Related]  

  • 36. Apolipoprotein a polymorphism predicts lipoprotein a concentration in renal transplant recipients.
    Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Rahbaninobar M
    Transplant Proc; 2005 Sep; 37(7):2925-8. PubMed ID: 16213263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of cyclosporin G (Nva2-cyclosporin) concentrations measured in whole blood by monoclonal fluorescence polarization immunoassay, monoclonal radioimmunoassay, and HPLC.
    Annesley TM; Coombs RC; Orsulak PJ
    Clin Chem; 1993 Jun; 39(6):1050-3. PubMed ID: 8504536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on post-transplant dyslipidemia in kidney transplant patients.
    Marubayashi S; Ohdan H; Tashiro H; Tokita D; Onoe T; Hayamizu K; Asahara T; Doi S; Okumoto S; Tanji C; Kawai T; Taniguchi Y; Fukuda Y; Dohi K
    Hiroshima J Med Sci; 2005 Jun; 54(2):39-45. PubMed ID: 15991596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cyclosporin-nicardipine interaction in the kidney-transplant patient].
    Kessler M; Renoult E; Jonon B; Vigneron B; Cao Huu T; Netter P
    Therapie; 1987; 42(3):273-5. PubMed ID: 3310316
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of cyclosporin: influence of rate-duration profile of an intravenous infusion in renal transplant patients.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1989 Mar; 27(3):353-7. PubMed ID: 2655684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.